Genisphere said this week that it has signed deals licensing its RNA target amplification and FlashTag Biotin microRNA labeling technologies to Affymetrix.
Genisphere said Affymetrix will use the technologies within its RNA microarray expression products, particularly for preclinical applications using formalin-fixed paraffin-embedded samples.
Financial terms of the arrangement were not disclosed.